S&P 500 Futures
(0.12%) 5 333.50 points

Dow Jones Futures
(0.06%) 40 161 points

Nasdaq Futures
(0.17%) 18 668 points

Oil
(0.29%) $80.29

Gas
(1.94%) $2.68

Gold
(1.43%) $2 451.90

Silver
(3.38%) $32.32

Platinum
(0.46%) $1 095.00

USD/EUR
(-0.09%) $0.919

USD/NOK
(-0.08%) $10.67

USD/GBP
(0.03%) $0.787

USD/RUB
(0.12%) $91.08

Realtime updates for Alkem Laboratories [ALKEM.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Last Updated18 May 2024 @ 02:59

25% discount on Stockinvest.us - Use code: Podcast

2.26% INR 5 438.25

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 02:59):

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally...

Stats
Today's Volume	12 829.00
Average Volume	222 397
Market Cap	650.22B
EPS	INR49.76 ( 2024-02-09 )
Next earnings date	( INR0 ) 2024-05-28
Last Dividend	INR10.00 ( 2023-08-09 )
Next Dividend	INR0 ( N/A )
P/E	41.33
ATR14	INR6.12 (0.11%)

Volume Correlation

Long: 0.42 (neutral)

Short: 0.00 (neutral)

Signal:(68.576) Neutral

Alkem Laboratories Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alkem Laboratories Correlation - Currency/Commodity

-0.02
( neutral )

-0.20
( neutral )

0.05
( neutral )

0.18
( neutral )

0.72
( moderate )

-0.12
( neutral )

Alkem Laboratories Financials

Annual	2022
Revenue:	INR115.99B
Gross Profit:	INR66.92B (57.70 %)
EPS:	INR82.31

FY	2022
Revenue:	INR115.99B
Gross Profit:	INR66.92B (57.70 %)
EPS:	INR82.31

FY	2022
Revenue:	INR105.12B
Gross Profit:	INR62.29B (59.25 %)
EPS:	INR137.63

FY	2021
Revenue:	INR87.47B
Gross Profit:	INR51.61B (59.00 %)
EPS:	INR132.57

Financial Reports:

No articles found.

Alkem Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR4.00 (N/A)	INR0 (N/A)	INR25.00 (N/A)	INR0 (N/A)	INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Alkem Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.90 - low (29.79%) | Divividend Growth Potential Score: 5.46 - Stable (9.18%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR9.70	2016-03-18
Last Dividend	INR10.00	2023-08-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	15	--
Total Paid Out	INR177.70	--
Avg. Dividend % Per Year	0.71%	--
Score	2.84	--
Div. Sustainability Score	3.90
Div.Growth Potential Score	5.46
Div. Directional Score	4.68	--

Next Divdend (Est)
(2024-08-08)

INR8.69 Estimate 7.41 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.84

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR13.00	0.65%
2019	INR16.00	0.83%
2020	INR25.00	1.20%
2021	INR30.00	1.02%
2022	INR34.00	0.93%
2023	INR35.00	1.17%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SOLARINDS.NS	Dividend Knight	2023-06-09	Annually	19	0.22%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%
GULPOLY.NS	Dividend Junior	2023-09-22	Annually	10	0.67%
BAYERCROP.NS	Dividend Junior	2023-08-03	Annually	15	1.25%
RAILTEL.NS	Dividend Knight	2023-08-24	Semi-Annually	4	1.19%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
EICHERMOT.NS	Dividend Knight	2023-08-14	Annually	28	0.59%
ADFFOODS.NS	Dividend Knight	2023-08-03	Sporadic	14	1.83%
SUPRIYA.NS	Dividend Junior	2023-09-15	Annually	3	0.10%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.125	1.500	7.51	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.163	1.500	9.30	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	18.58	1.000	4.23	4.23	[3 - 30]
operatingCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.597	1.000	3.38	3.38	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.63	8.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	41.33	1.000	5.93	0	[1 - 100]
returnOnEquityTTM	0.163	2.50	9.55	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.827	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	49.21	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.30	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0466	1.000	-1.336	0	[0.1 - 0.5]
Total Score				5.46

Alkem Laboratories Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Alkem Laboratories

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.